Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.45 USD | -1.11% | -7.87% | +147.22% |
Mar. 22 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
Mar. 21 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.22% | 259M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.11% | 22.2B | |
-16.53% | 21.23B | |
-10.05% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.
- BofA Securities Starts Pyxis Oncology at Neutral With $16 Price Target